Re: ZHCLF up 290% to $0.16...question
in response to
by
posted on
Dec 14, 2020 11:48AM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
Well I own ZHCLF (bought on the open market OTC) and now I am able to and have voted in the Zenith Capital Corp (Calgary) Annual & Speical Meeting. I guess this confirms that ZHCLF is in fact shares of ZCC (Calgary) (Zenith Epigenetics).